Skip to main content
Log in

Narcolepsy

Increased L–PGDS (β–trace) levels correlate with excessive daytime sleepiness but not with cataplexy

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objectives

Alterations in the prostaglandin-D–system have been found in animal sleep experiments and disorders that present with hypersomnia or sleep disturbances. The recently demonstrated involvement of the leptomeningeal lipocalin–type prostaglandin–Dsynthase (L–PGDS) (β–trace) in human physiological sleep encouraged us to investigate its role in the pathophysiology of narcolepsy.

Methods

In a pilot study, serum LPGDS and melatonin concentrations were assessed in 14 narcoleptic patients during undisturbed sleep and total sleep deprivation, compared with those from 14 healthy controls during undisturbed sleep. Excessive daytime sleepiness was measured by a standardized questionnaire (Epworth sleepiness scale, ESS).

Results

In narcoleptic patients, markedly increased baseline L–PGDS levels were significantly correlated with the ESS score, but not with the degree of cataplexy. Serum L–PGDS concentrations in patients as well as in controls followed a time–dependent fluctuation with evening increases, highest values during the night and in the morning. Compared with controls, patients exhibited significant/increased amplitude of circulating L–PGDS without any suppression by total sleep deprivation.

Conclusion

These findings indicate that the prostaglandin–D–system contributes to the pathophysiology of narcolepsy, e. g. the regulation of excessive daytime sleepiness. Since it has been suggested that L–PGDS is also involved in neurodegenerative disorders, there may be a more specific role of the prostaglandin– D–system in narcoleptic aetiogenesis. Moreover, its linkage with the immune system as well as with human sleep regulation offers a direct access for investigating both systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Thoracic Society (1989) Indications and standards for cardiopulmonary sleep studies.Am Rev Respir Dis 139:559–567

    Google Scholar 

  2. Beuckmann CT, Yanagisawa M (2002) Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med 80:329–342

    Article  PubMed  CAS  Google Scholar 

  3. Cross EM, Chaffin WW (1982) Use of the binomial theorem in interpreting results of multiple tests of significance. Educational and Psychological Management 42:25–34

    Google Scholar 

  4. Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, Maly F, Besset A, Touchon J, Billiard M, Tafti M, Bassetti CL (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 74(12):1667–1673

    Article  PubMed  CAS  Google Scholar 

  5. Eguchi Y, Eguchi N,Oda H, Seiki K, Kijima Y,Matsu-Ura Y,Urade Y, Hayaishi O (1997) Expression of lipocalin-type prostaglandin D synthase (β-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94:14689–14694

    Article  PubMed  CAS  Google Scholar 

  6. Hayaishi O (1996) Tryptophan, oxygenase, and sleep. Adv Exp Med Biol 398:3–11

    PubMed  CAS  Google Scholar 

  7. Hirawa N, Uehara Y,Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S (2002) Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 39(2Pt2):449–454

    Article  PubMed  CAS  Google Scholar 

  8. Johns MW (2000) Sensitivity and specificity of the multiple sleep latency test (MSLT), maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9:5–11

    PubMed  CAS  Google Scholar 

  9. Jordan W, Tumani H, Cohrs S, Eggert S, Rodenbeck A, Brunner E, Rüther E, Hajak G (2004) Prostaglandin-D-synthase (β-trace) and melatonin in human healthy sleep. Sleep 27(5):867–874

    PubMed  Google Scholar 

  10. Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH (2002) Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep 25(7):733–736

    PubMed  Google Scholar 

  11. Melegos DN, Freedman MS, Diamandis EP (1997) Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54:463–474

    Article  PubMed  CAS  Google Scholar 

  12. Melegos DN, Grass L, Pierratos A, Diamandis EP (1999) Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53:32–37

    Article  PubMed  CAS  Google Scholar 

  13. Nishino S, Mignot E, Kilduff TS, Sakai T, Hayaishi O, Dement WC (1990) Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs. Biol Psychiatry 28:904–910

    Article  PubMed  CAS  Google Scholar 

  14. Onoe H, Ueno R, Fujita I, Nishino H, Oomura Y, Hayaishi O (1988) Prostaglandin D2, a cerebral sleepinducing substance in monkeys. Proc Natl Acad Sci USA 85:4082–4086

    PubMed  CAS  Google Scholar 

  15. Pinzar E, Kanaoka Y, Inui T, Eguchi N, Urade Y, Hayaishi O (2000) Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci USA 97(9):4903–4907

    Article  PubMed  CAS  Google Scholar 

  16. Ragolia L, Palaia T, Frese L, Fishbane S, Maesaka JK (2001) Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells. Neuroreport 12(12):2623–2628

    PubMed  CAS  Google Scholar 

  17. Rechtschaffen A,Kales A (1968) A manual for standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: Public Health Service, US Government Printing Office:1–12

  18. Reiber H (2003) Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21:79–96

    PubMed  CAS  Google Scholar 

  19. Rodenbeck A, Huether G, Rüther E, Hajak G (1998) Altered circadian melatonin secretion patterns in relation to sleep in patients with chronic sleepwake rhythm disorders. J Pineal Res 25:201–210

    PubMed  CAS  Google Scholar 

  20. Scammell TE (2003) The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53:154–166

    Article  PubMed  Google Scholar 

  21. Tumani H, Nau R, Felgenhauer K (1998) β-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44:882–889

    PubMed  CAS  Google Scholar 

  22. Urade Y, Hayaishi O (1999) Prostaglandin D2 and sleep regulation. Biochem Biophys Acta 1436:606–615

    PubMed  CAS  Google Scholar 

  23. Watanabe K, Urade Y, Mäder M, Murphy C, Hayaishi O (1994) Identification of β-trace as prostaglandin D synthase. Biochem Biophys Res Commun 203(2):1110–1116

    Article  PubMed  CAS  Google Scholar 

  24. Wu MF, John J, Maidment N, Lam HA, Siegel JM (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 283(5):R1079–R1086

    PubMed  Google Scholar 

  25. Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E (2003) Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 23(8):3555–3560

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Jordan MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jordan, W., Tumani, H., Cohrs, S. et al. Narcolepsy. J Neurol 252, 1372–1378 (2005). https://doi.org/10.1007/s00415-005-0870-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0870-4

Key words

Navigation